Role of dopaminergic receptors in glaucomatous disease modulation

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Pescosolido, Nicola ^a   Parisi, Francesco ^a   Russo, Paola ^a   Buomprisco, Giuseppe ^a   Nebbioso, Marcella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BROMOCRIPTINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; FENOLDOPAM; HALOPERIDOL; IBOPAMINE; LERGOTRILE; LEVODOPA; NORADRENALIN; PERGOLIDE; SCH 23990; TIMOLOL; UNCLASSIFIED DRUG; DOPAMINE;

ANTIHYPERTENSIVE ACTIVITY; AQUEOUS HUMOR; CILIARY BODY; CILIARY BODY EPITHELIUM; CLOSED ANGLE GLAUCOMA; DOPAMINERGIC SYSTEM; GLAUCOMA; HAPLORHINI; HUMAN; INTRAOCULAR PRESSURE; NONHUMAN; RABBIT; REVIEW; ANIMAL; BIOLOGICAL MODEL; INTRAOCULAR HYPERTENSION; METABOLISM; COMPLICATION;

ANIMALS; AQUEOUS HUMOR; DOPAMINE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MODELS, BIOLOGICAL; OCULAR HYPERTENSION; RECEPTORS, DOPAMINE;

EID: 84880169369     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/193048     Document Type: Review

References (35)

1. Quigley H. A., Broman A. T., The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 2006 90 3 262 267 2-s2.0-33644655886 10.1136/bjo.2005.081224
2. Quigley H. A., Glaucoma. The Lancet 2011 377 9774 1367 1377 2-s2.0-79954621581 10.1016/S0140-6736(10)61423-7
3. Zhong Y., Wang J., Luo X., Integrins in trabecular meshwork and optic nerve head: possible association with the pathogenesis of glaucoma. Journal of Biomedicine and Biotechnology 2013 2013 8 10.1155/2013/202905 202905
4. Pescosolido N., Cavallotti C., Rusciano D., Nebbioso M., Trabecular meshwork in normal and pathological eyes. Ultrastructural Pathology 2012 36 2 102 107 2-s2.0-84859339022 10.3109/01913123.2011.634090
5. Scarsella G., Nebbioso M., Stefanini S., Librando A., Pescosolido N., Degenerative effects in rat eyes after experimental ocular hypertension. European Journal of Histochemistry 2012 56 4, article e42 265 271 10.4081/ejh.2012.e42
6. Brubaker R. F., Measurement of uveoscleral outflow in humans. Journal of Glaucoma 2001 10 5 S45 S48 2-s2.0-0035159266
7. Cavallotti C., Pescosolido N., Pescosolido V., Iannetti G., Determination of dopamine D1 receptors in the human uveo scleral tissue by light microscope autoradiography. International Ophthalmology 2001 23 3 171 179 2-s2.0-0034948542 10.1023/A:1010611419602
8. Kingman S., Glaucoma is second leading cause of blindness globally. Bulletin of the World Health Organization 2004 82 11 887 888 2-s2.0-14544301551
9. Green K., Hensley A., Lollis G., Dopamine stimulation of passive permeability and secretion in the isolated rabbit ciliary epithelium. Experimental Eye Research 1979 29 4 423 427 2-s2.0-0018608227
10. Libet B., Which postsynaptic action of dopamine is mediated by cyclic AMP? Life Sciences 1979 24 12 1043 1057 2-s2.0-0018425482
11. Lograno M. D., Daniele E., Govoni S., Biochemical and functional evidence for the presence of dopamine D1 receptors in the bovine ciliary body. Experimental Eye Research 1990 51 5 495 501 2-s2.0-0025096128 10.1016/0014-4835(90)90079-A
12. Potter D. E., Do dopamine and dopamine receptors have roles in modulating function in the anterior segment? The evidence. Progress in Retinal and Eye Research 1996 15 1 103 111 2-s2.0-0030056359 10.1016/1350-9462(95)00005-4
13. Prünte C., Nuttli I., Markstein R., Kohler C., Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits. Journal of Neural Transmission 1997 104 2-3 111 123 2-s2.0-0030943459
14. Bucolo C., Leggio G. M., Maltese A., Castorina A., D'Agata V., Drago F., Dopamine-3 receptor modulates intraocular pressure: implications for glaucoma. Biochemical Pharmacology 2012 83 5 680 686 2-s2.0-84856110526 10.1016/j.bcp.2011.11.031
15. Shannon R. P., Mead A., Sears M. L., The effect of dopamine on the intraocular pressure and pupil of the rabbit eye. Investigative Ophthalmology 1976 15 5 371 380 2-s2.0-0017195808
16. Green K., Elijah D., Drug effects on aqueous humor formation and pseudofacility in normal rabbit eyes. Experimental Eye Research 1981 33 3 239 245 2-s2.0-0019426512
17. Potter D. E., Burke J. A., Chang F. W., Alteration in ocular function induced by phenylethylamine analogs of dopamine. Current Eye Research 1984 3 6 851 859 2-s2.0-0021262734
18. Mancino R., Cerulli L., Ricci A., Amenta F., Direct demonstration of dopamine D1-like receptor sites in the ciliary body of the rabbit eye by light microscope autoradiography. Naunyn-Schmiedeberg's Archives of Pharmacology 1992 346 6 644 648 2-s2.0-0026678178
19. Stone R. A., Laties A. M., Hemmings H. C. Jr., Ouimet C. C., Greengard P., DARPP-32 in the ciliary epithelium of the eye: a neurotransmitter-regulated phosphoprotein of brain localizes to secretory cells. The Journal of Histochemistry and Cytochemistry 1986 34 11 1465 1468 2-s2.0-0022528751
20. Potter D. E., Burke J. A., Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Current Eye Research 1983 2 5 281 288 2-s2.0-0020356812
21. Potter D. E., Burke J. A., An in vivo model for dissociating alpha 2-and DA2-adrenoceptor activity in an ocular adnexa: utility of the cat nictitating membrane preparation. Current Eye Research 1984 3 11 1289 1298 2-s2.0-0021679825
22. Savolainen J., Rautio J., Razzetti R., Järvinen T., A novel D2-dopaminergic and alpha2-adrenoceptor receptor agonist induces substantial and prolonged IOP decrease in normotensive rabbits. The Journal of Pharmacy and Pharmacology 2003 55 6 789 794 2-s2.0-0037530381 10.1211/002235703765951393
23. Chu E., Chu T.-C., Potter D. E., Mechanisms and sites of ocular action of 7-hydroxy-2- dipropylaminotetralin: a dopamine3 receptor agonist. Journal of Pharmacology and Experimental Therapeutics 2000 293 3 710 716 2-s2.0-0034049765
24. Mekki Q. A., Hassan S. M., Turner P., Bromocriptine lowers intraocular pressure without affecting blood pressure. The Lancet 1983 1 8336 1250 1251 2-s2.0-0020533328
25. Mekki Q. A., Warrington S. J., Turner P., Bromocriptine eyedrops lower intraocular pressure without affecting prolactin levels. The Lancet 1984 1 8371 287 288 2-s2.0-0021358662 10.1016/S0140-6736(84)90162-4
26. Lustig A., Does bromocriptine enhance the effect of drugs that reduce intraocular pressure? Deutsche Medizinische Wochenschrift 1983 108 43 1656 1657 2-s2.0-0021114501
27. Elibol O., Güler C., Arici K., Topalkara A., Demircan S., The determination of additive effect and intraocular pressure lowering effects of 0.05% bromocriptine and 0.25% timolol. International Ophthalmology 1997 20 1-3 53 55 2-s2.0-0030437346
28. Al-Sereiti M. R., Quik R. F. P., Hedges A., Turner P., Antagonism by domperidone of the ocular hypotensive effect of pergolide. European Journal of Clinical Pharmacology 1990 38 5 461 463 2-s2.0-0025329060 10.1007/BF02336684
29. Virno M., Gazzaniga A., Taverniti L., Pecori Giraldi J., de Gregorio F., Dopamine, dopaminergic drugs and ocular hypertension. International Ophthalmology 1992 16 4-5 349 353 2-s2.0-0026661247 10.1007/BF00917989
30. Karnezis T. A., Murphy M. B., Weber R. R., Nelson K. S., Tripathi B. J., Tripathi R. C., Effects of selective dopamine-1 receptor activation on intraocular pressure in man. Experimental Eye Research 1988 47 5 689 697 2-s2.0-0023723710
31. Piltz J. R., Stone R. A., Boike S., Everitt D. E., Shusterman N. H., Audet P., Zariffa N., Jorkasky D. K., Fenoldopam, a selective dopamine-1 receptor agonist, raises intraocular pressure in males with normal intraocular pressure. Journal of Ocular Pharmacology and Therapeutics 1998 14 3 203 216 2-s2.0-0031806470
32. Prünte C., Flammer J., The novel dopamine D-1 antagonist and D-2 agonist, SDZ GLC-756, lowers intraocular pressure in healthy human volunteers and in patients with glaucoma. Ophthalmology 1995 102 9 1291 1297 2-s2.0-0029134956
33. Magacho L., Lima F. E., Costa M. L., Fayad F. A., Guimarães N. L., Avila M. P., Ibopamine provocative test and glaucoma: consideration of factors that may influence the examination. Current Eye Research 2004 28 3 189 193 2-s2.0-1642287435 10.1076/ceyr.28.3.189.26252
34. Hepsen I. F., Yilmaz H., Keskin U. C., The comparison of topical ibopamine 2% with tonography to identify the outflow resistance in eyes with ocular hypertension. Ophthalmic Research 2005 37 1 17 22 2-s2.0-18644367963 10.1159/000082779
35. Virno M., Sampaolesi R., Pecori Giraldi J., de Gregorio F., Taloni M., Brusini P., di Staso S., Stecchi G., Ibopamine: D1-dopaminergic agonist in the diagnosis of glaucoma. Journal of Glaucoma 2011 2-s2.0-80053174054 10.1097/IJG.0b013e3182311db4